These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21395099)

  • 1. [The bioavailability of zinc oxide nanoparticles. Study using methods of radionuclide indicators].
    Raspopov RV; Buzulukov IuP; Marchenkov NS; Solov'ev VIu; Demin VF; Kalistratova VS; Gmoshinskiĭ IV; Khotimchenko SA
    Vopr Pitan; 2010; 79(6):14-8. PubMed ID: 21395099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of using zinc oxide nanoparticles in nutrition. Experiments on the laboratory animal].
    Raspopov RV; Trushina EN; Mustafina OK; Tananova ON; Gmoshinskiĭ IV; Khotimchenko SA
    Vopr Pitan; 2011; 80(5):39-44. PubMed ID: 22238947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles.
    Konduru NV; Murdaugh KM; Sotiriou GA; Donaghey TC; Demokritou P; Brain JD; Molina RM
    Part Fibre Toxicol; 2014 Sep; 11():44. PubMed ID: 25183210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice.
    Chen JK; Shih MH; Peir JJ; Liu CH; Chou FI; Lai WH; Chang LW; Lin P; Wang MY; Yang MH; Yang CS
    Analyst; 2010 Jul; 135(7):1742-6. PubMed ID: 20505857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of 65Zn through the skin of rats.
    Hallmans G; Lidén S
    Acta Derm Venereol; 1979; 59(2):105-12. PubMed ID: 84485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice.
    Li CH; Shen CC; Cheng YW; Huang SH; Wu CC; Kao CC; Liao JW; Kang JJ
    Nanotoxicology; 2012 Nov; 6(7):746-56. PubMed ID: 21950449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of the tissue distribution of silver nanoparticles of different sizes.
    Lankveld DP; Oomen AG; Krystek P; Neigh A; Troost-de Jong A; Noorlander CW; Van Eijkeren JC; Geertsma RE; De Jong WH
    Biomaterials; 2010 Nov; 31(32):8350-61. PubMed ID: 20684985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
    Bhavsar MD; Amiji MM
    J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice.
    Matsumura M; Takasu N; Nagata M; Nakamura K; Kawai M; Yoshino S
    J Immunotoxicol; 2010; 7(3):232-7. PubMed ID: 20507255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface properties of zinc oxide nanoparticles studied by inverse gas chromatography.
    Przybyszewska M; Krzywania A; Zaborski M; Szynkowska MI
    J Chromatogr A; 2009 Jul; 1216(27):5284-91. PubMed ID: 19464015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and tissue distribution of neutron-activated zinc oxide nanoparticles and zinc nitrate in mice: effects of size and particulate nature.
    Yeh TK; Chen JK; Lin CH; Yang MH; Yang CS; Chou FI; Peir JJ; Wang MY; Chang WH; Tsai MH; Tsai HT; Lin P
    Nanotechnology; 2012 Mar; 23(8):085102. PubMed ID: 22293282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zinc on biological half-lives of 65Zn in whole body and liver and on distribution of 65Zn in different organs of rats following nickel toxicity.
    Sidhu P; Garg ML; Dhawan DK
    Biol Trace Elem Res; 2004; 102(1-3):173-88. PubMed ID: 15621937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biokinetics and dose estimation of 65Zn in the salivary gland and male reproductive organs.
    Matsumoto M; Homma-Takeda S; Nishimura Y
    Radiat Prot Dosimetry; 2007; 127(1-4):163-8. PubMed ID: 17627954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J; Tabbakhian M; Mohammadi MY
    J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of zinc on the status of hepatic trace elements and biokinetics of 65Zn in ethanol treated rats.
    Dhawan D; Pathak A; Dani V; Pathak R; Mahmood A
    Indian J Exp Biol; 2005 Mar; 43(3):259-63. PubMed ID: 15816413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioavailability of nanoparticles of ferric oxide when used in nutrition. Experimental results in rats].
    Raspopov RV; Trushina ÉN; Gmoshinskiĭ IV; Khotimchenko SA
    Vopr Pitan; 2011; 80(3):25-30. PubMed ID: 21842750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
    Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM
    J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
    De Jong WH; Hagens WI; Krystek P; Burger MC; Sips AJ; Geertsma RE
    Biomaterials; 2008 Apr; 29(12):1912-9. PubMed ID: 18242692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.
    Shaikh J; Ankola DD; Beniwal V; Singh D; Kumar MN
    Eur J Pharm Sci; 2009 Jun; 37(3-4):223-30. PubMed ID: 19491009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.